Introduction
In mammals the NOTCH gene family comprises four related genes that encode transmembrane receptor proteins which are involved in cell-fate decisions during development (Artavanis-Tsakonas et al., 1999) . The NOTCH-4/INT-3 gene is frequently rearranged by mouse mammary tumor virus (MMTV) proviral DNA integration in mammary tumors of feral mouse strains (Gallahan et al., 1997; Robbins et al., 1992; Sarkar et al., 1994) . The transforming rearrangement of NOTCH-4/ INT-3 results from the expression of the intracellular domain of the gene product under control of the MMTV promoter and represents a gain-of-function mutation. Expression of this`activated' form of NOTCH-4/INT-3 in transgenic mice under the control of either the MMTV long terminal repeat (LTR) or the Whey Acidic Protein (WAP) promoter leads to a severe impairment of mammary gland function and to the development of mammary adenocarcinomas (Gallahan et al., 1996; Jhappan et al., 1992; Smith et al., 1995) .
Other members of the NOTCH gene family are activated in various type of malignancies. For instance, the chromosomal translocation t(7;9)(q34;q34.3) in human T-cell acute lymphoblastic leukemia leads to the expression of a truncated NOTCH-1/TAN-1 gene product which is missing most of the extracellular domain (Aster et al., 1994; Ellison et al., 1991) . NOTCH-1 is also activated by retroviral insertional mutagenesis in certain strains of transgenic mice in a manner that is similar to those observed at NOTCH-4/ INT-3 in MMTV infected feral mice. Thus, in c-erbB2 transgenic mice infected with MMTV some mammary tumors contain viral induced rearrangements of NOTCH-1 (Jolicoeur et al., 1998) . Similarly, thymic lymphomas in murine leukemia virus (MuLv) infected cmyc transgenic mice contain a viral induced rearrangements of NOTCH-1 (Girard et al., 1996) . Expression of genetically activated NOTCH-2 is also thought to contribute to the induction of thymic lymphomas in cats (Rohn et al., 1996) . In these cases the feline leukemia virus (FeLV) has been shown to transduce the region of NOTCH-2 which is analogus to the portion of NOTCH-1 whose expression is activated by chromosomal translocation or viral induced rearrangement. In each case, whether by chromosomal translocation or viral induced rearrangement, expression of truncated NOTCH-1 and NOTCH-2 RNA appears to represent a gain-of-function mutation. Further evidence for this conclusion is the demonstration that expression of NOTCH-1 or NOTCH-2 ICD in E1A-immortalized baby rat kidney cells confers on them the ability to grow in soft agar and form tumors in nude mice (Capobianco et al., 1997) .
In humans, NOTCH-4/INT-3 has been reported to be normally expressed in all adult tissues as a major 6.5 Kb RNA species as well as a minor 9.0 Kb splice variant (Li et al., 1998) . We initiated a survey of human breast, colon, and lung carcinoma cell lines for evidence of the expression of RNA species from genetically`activated' NOTCH-4/INT-3. Here we report the identi®cation and characterization of a 1.8 Kb NOTCH-4/INT-3 RNA species in several tumor cell lines that is normally only detected at high levels in the testis.
Results

NOTCH-4/INT-3 RNA expression in normal human tissues and tumor cell lines
We and others have previously shown that NOTCH-4/ INT-3 is expressed in several adult mouse tissues as a 6.7 Kb RNA species (Gallahan and Callahan, 1997; Uyttendaele et al., 1996) . In the mouse testis, NOTCH-4/ INT-3 is expressed primarily as a 1.5 and 1.1 Kb RNA species (Uyttendaele et al., 1996) . Whether these RNA species correspond to splice variants or arise from a cryptic promoter within introns near the 3' end of the gene has not been de®nitively determined. In a survey of normal human tissue RNA, Li et al. (1998) reported a major 6.7 Kb NOTCH-4/INT-3 RNA species and a minor 9.3 Kb RNA species. The latter transcript is the result of incomplete splicing. As shown in Figure 1 , in addition to the 6.7 and 9.3 Kb NOTCH-4/INT-3 RNA species, we also detected a major 1.8 Kb RNA species in the testis. Only low levels of this RNA species could be detected in the spleen, prostate, ovary, and small intestine.
We examined eight breast, seven lung and four colon carcinoma cell lines for NOTCH-4/INT-3 RNA expression (Figure 2 ). The 6.7 Kb RNA species was detected in seven out of eight breast carcinoma cell lines (Figure 2a ), whereas only low levels of this RNA species could be found in the lung and colon carcinoma cell lines (Figure 2b ). Interestingly, easily detectable levels of the 1.8 Kb NOTCH-4/INT-3 RNA species were observed in the breast carcinoma cell lines BT474 and HS578, the small cell lung carcinoma cell line H69, the non-small cell lung carcinoma cell line H157, and the colon carcinoma cell line SW480 (Figure 2 ).
Identi®cation of the transcription start site for the 1.8 Kb NOTCH-4/INT-3 RNA species in testis and tumor cell line RNAs Using cDNA probes corresponding to dierent regions of NOTCH-4/INT-3 RNA, it was ascertained that the 1.8 Kb RNA species corresponds to sequences at the 3' end of the gene (data not shown). We have used primer extension analysis to distinguish between the possibilities that the 1.8 Kb RNA species is a splice variant or is initiatated from a cryptic promoter within a NOTCH-4/INT-3 intron. A 37-mer oligonucleotide in exon 27, corresponding to 50417-50453 bp of the complete genomic DNA sequence (Li et al., 1998) , was end-labeled with g-32 P-ATP and used for primer extension analysis on SW480 RNA. As shown in Figure 3 , two potential transcription start sites (50314 and 50333 bp of NOTCH-4/INT-3 genomic DNA (Li et al., 1998) ) were detected in intron 26. To provide evidence that expression of the 1.8 NOTCH-4/INT-3 RNA species in the testis and all of the positive tumor cell lines is initiated within intron 26 we carried out a reverse transcriptase-polymerase chain reaction (RT ± PCR) analysis of RNA from some of the cell lines tested by Northern blot analysis. Shown in Figure 4 is a partial exon/intron map of NOTCH-4/ INT-3 indicating the location and orientation of the various primers used in this experiment. The 964R/841 primer pair is located in exons 27 and 28, respectively and were used to con®rm the expression of NOTCH-4/ INT-3 RNA (Figure 4b ). Primers 1061 and 1088 correspond to sequences 5' of those identi®ed in the primer extension experiment in intron 26. When these primers were paired with primer 841 no PCR product was detected (Figure 4c,d ). In contrast, primer 1081 which corresponds to intron 26 sequences detected in the primer extension product when paired with primer 841 ampli®ed the expected PCR fragment in cDNA prepared from testis, and SW480, NCI-H69, Hs578 cell lines. Consistent with the results of Northern blot analysis the 1081/841 primer pair failed to amplify a fragment with cDNA prepared from MCF10A normal mammary epithelial cells and the ZR-75-1 breast tumor cell line.
Identi®cation of the protein encoded by the 1.8 Kb NOTCH-4/INT-3 RNA species
Within exon 27 there is a potential translational initiation start signal (ATG) which is preceded by a consensus translation initiation Kozac box (ACACCCCTGATG, see Figure 3 or 4) (Kozak, 1989) . This methionine residue corresponds to the twelfth residue of the ®rst 31 amino acid Ankyrin repeat of the NOTCH-4/INT-3 ICD. To determine whether this potential translation start signal is active, the segment of NOTCH-4/INT-3 corresponding to the coding region of the 1.8 Kb RNA species (nucleotides 4855 ± 6102 of the full-length mRNA (Li et al., 1998) ) was cloned into the NheI and XhoI sites of the pcDNA3.1(7) expression vector (Invitrogen). Using this expression vector in the TNT Coupled Transcription/Translation System (Promega) a 43 kDa product was detected by SDS ± PAGE analysis ( Figure 5a ). To con®rm and extend this ®nding to cells expressing the 1.8 Kb NOTCH-4/INT-3 RNA species, a Western blot analysis was performed on protein extracts electrophoretically separated by denaturing PAGE. We used a rabbit polyclonal serum raised against an 18-mer peptide corresponding to a conserved region (16 out of 18 identical amino acids residues between mouse and human, see Materials and methods) in the sixth Ankyrin repeat of the mouse NOTCH-4/INT-3 ICD (Gallahan et , 1996) . As shown in Figure 5b (lanes 2 ± 6), multiple bands were detected in protein extracts of the dierent cell lines. The multiple bands observed in Figure 5b undoubledly re¯ect, in part, the previously noted complex array of proteolytic cleavage products that accumulate during maturation of NOTCH proteins De Strooper et al., 1999; Hardy et al., 1999; Logeat et al., 1998; Struhl et al., 1999; Ye et al., 1999) . The speci®city of this reactivity was demonstrated by the ability of the immunogenic peptide to block the reaction (Figure 5c ). The major band in the testis corresponds to a 43 kDa protein species which is also readily detected in the cell lines which express the 1.8 Kb NOTCH-4/INT-3 RNA species (lanes 2 ± 4). The MCF10A and ZR-75-1 cell lines which had no detectable 1.8 Kb NOTCH-4/INT-3 RNA also had no detectable 43 kDa NOTCH-4/INT-3 protein.
Biological activity of the truncated NOTCH-4/INT-3 ICD
In previous work we have shown that expression of the mouse NOTCH-4/INT-3 ICD in the normal mouse mammary epithelial HC11 cell line conferred on the cells the ability to grow in soft agar (Robbins et al., 1992) . To determine whether expression of truncated NOTCH-4/INT-3 ICD which we have detected in human tumor cell lines, also has a biological eect on the growth properties of`normal' mammary epithelial cells in culture, we developed the expression vector depicted in Figure 6a (see Materials and methods). The NOTCH-4/INT-3 transgene is similar to that used for in vitro translation except that sequences encoding a FLAG Tag were added in-frame at the 3' end of the NOTCH-4/INT-3 coding sequences and were cloned into the pMAMneo expression vector (Clontech). This vector was designated pMcF. The control vector containing no insert was designated pM. In this vector system, transcription of the transgene is under the control of a hybrid Rous Sarcoma Virus (RSV) enhancer sequences linked to the MMTV LTR and is upregulated in the presence of the glucocordicoid, dexamethasone. These vectors were transfected into thè normal' human MCF10A mammary epithelial cell line. In the presence of dexamethasone, soft agar colonies were detected with the pMcF vector (Figure 6b ) whereas in the absence of dexamethasone the number of colonies detected ( Figure 6c ) was not signi®cantly dierent from those detected with the pM vector, with or without dexamethasone (Figure 6d ).
To con®rm that the observed biological eects on the growth properties of MCF10A cells was a consequence of truncated NOTCH-4/INT-3 ICD expression, protein extracts of MCF10A cells transfected with pMcF (+/7Dex) and pM (+/7Dex) were tested for the presence of the transgenic protein by a Western blot analysis. As shown in Figure 7 , the 43 kDa transgenic protein was detected with the FLAG antisera only in the protein extract from MCF10A cells transfected with pMcF vector and grown in the presence of dexamethasone.
Discussion
Genetic and molecular biological analysis of Drosophila and mammalian NOTCH signaling pathways have demonstrated that the NOTCH intracellular domain (ICD) expressed independent of the extracellular domain represents a constitutively active form of the receptor (reviewed in Artavanis-Tsakonas et al., 1999) . In the case of mouse NOTCH-4/INT-3, integration of the MMTV genome into exons 21, 22, or 23 represents a gain-of-function mutation resulting in the expression of`activated' NOTCH-4/INT-3 ICD (Gallahan and Callahan, 1997) . In cultured normal HC11 mouse mammary epithelial cells`activated' NOTCH-4/INT-3 ICD confers anchorage-independent growth in soft agar (Robbins et al. 1992) . In other studies, Figure 5 The translation product of the 1.8 Kb NOTCH-4/INT-3 RNA species. (a) In vitro translation product of the 1.8 Kb NOTCH-4/INT-3 RNA species. A PCR product corresponding to nucleotides 4855 ± 6102 bp of the Li et al. (1998) cDNA (GenBank accession #U95299), was cloned into pcDNA3.1(7) (Invitrogen). The protein encoded by the PCR product was synthesized using TNT Coupled Transcription/Translation System (Promega) and was analysed by electrophoresis on a 10% SDSpolyacrylamide gel (SDS ± PAGE) and autoradiography. Lane 1, pcDNA3.1(7)-NOTCH-4/INT-3. Lane 2, pcDNA3.1(7). (b, c) Western blot analysis of protein extracts from human tissue and tissue culture cell lines using anti-NOTCH-4/INT-3 a341 polyclonal rabbit antibody (Materials and methods). In each lane 50 mg of protein was analysed by 10% SDS ± PAGE followed by transfer to PVDF membrane (Immobilon-P, Millipore) and Western blotting with rabbit serum anti-NOTCH-4/INT-3 a341. et al. (1998) have shown that activated NOTCH-4/INT-3 expression in the mouse mammary epithelial TAC-2 cell line inhibits its capability to undergo branching morphogenesis. In transgenic mouse strains expressing activated NOTCH-4/INT-3 ICD there is a profound alteration in mammary gland development including a 100% penetrance for mammary tumor development (Gallahan et al., 1996; Jhappan et al., 1992; Smith et al., 1995) . In Drosophila, signaling by activated Notch is mediated through the interaction between the Notch ICD and the transcription factor, suppressor of hairless (Su(H)) (reviewed in Artavanis-Tsakonas et al., 1999) . The region of Notch ICD located between the transmembrane domain and the Ankyrin/CDC10 repeat sequences binds Su(H) (Matsuno et al., 1997) . The Ankyrin/CDC10 repeats are also necessary but not sucient for Su(H) binding. One consequence of the Notch ICD-Su(H) interaction is up-regulation of expression of basic helix ± loop ± helix (bHLH) genes such as md in the Enhancer of Split (E(spl)) locus (Bailey et al., 1995; Lecourtois et al., 1995). In several Novel NOTCH-4/INT-3 RNA species in human tumor cell lines A Imatani and R Callahan independent studies of`activated' mouse NOTCH-1 a similar scenario has been described. In these cases the mammalian homolog of Su(H), CBF-1/RBPJk, when complexed with the NOTCH-1 ICD activates the expression of the murine homolog HES-1 (Sasai et al., 1992) of the Drosophila bHLH hairy gene (Jarriault et al., 1995; Kopan et al., 1994 Kopan et al., , 1996 . In protein interaction studies, using the yeast two hybrid system (reviewed in Aspenstrom et al., 1995), we have found that CBF-1/RBPJk is highly promiscuous in its interactions with the ICD of all members of the murine NOTCH family (Shu and Callahan, unpublished data). Thus it seems possible that many of the phenotypic consequences of`activated' transgenic NOTCH-4/INT-3 expression on mammary epithelium is mediated through the interaction of CBF-1/RBPJk with the NOTCH-4/INT-3 ICD.
There is, however, a large body of evidence suggesting that there are Su(H)/CBF-1 independent components of the NOTCH signaling pathway (Lecourtois and Schweisguth, 1995; Matsuno et al., 1997; Shawber et al., 1996) . For instance, in Drosophila deletion analysis of the NOTCH ICD has revealed that expression of the Ankyrin repeats 1 ± 5 in the absence of amino acid residues N-terminal and C-terminal to them has novel phenotypic consequences such as in the development of eye discs (Matsuno et al., 1997) . Similarly NOTCH-1 regulation of myogenesis has been shown to be dependent on the portion of mouse NOTCH-1 encoding the Ankyrin repeats and sequences C-terminal to them (Shawber et al., 1996) . Expression of this form of NOTCH-1 ICD is constitutively active and inhibits muscle dierentiation but does not interact with CBF-1 or upregulate endogenous HES-1 expression. In fact, exogenous expression of HES-1 in C2C12 myoblasts does not block myogenesis (Shawber et al., 1996) . Thus NOTCH signaling activates at least two dierent pathways one in which CBF-1 is an intermediate and one in which the mediator has yet to be identi®ed.
In the present study a 1.8 Kb NOTCH-4/INT-3 RNA species was detected in a survey of human breast, colon, and lung carcinoma cell lines. This RNA species is observed at high levels normally only in the human testis. It has the capability of encoding a 43 kDa portion of the NOTCH-4/INT-3 ICD which lacks the CBF-1 binding region but does contain the Ankyrin repeat sequences and amino acid residues C-terminal to them. Expression of this NOTCH-4/INT-3 RNA species in the MCF10A`normal' human mammary epithelial tissue culture cells confers on them the ability to grow in soft agar. This suggests that expression of the 1.8 Kb NOTCH-4/INT-3 RNA species, like the one activated by MMTV in mouse mammary tumors, represents a NOTCH-4/INT-3 gain-of-function event. However, in this case NOTCH-4/INT-3 activity would be mediated through a CBF-1 independent signaling pathway which also does not require a complete Nterminal Ankyrin repeat element.
Based on our data we propose that there is a cryptic transcription promoter within intron-26 of human NOTCH-4/INT-3 which, when active, initiates the expression of the NOTCH-4/INT-3 1.8 Kb RNA species. The location of this putative transcription promoter is approximately 80 bp 3' of a highly repetitive Alu repeat sequences. The molecular mechanism(s) which restricts high level expression of this RNA species to the testis and the function(s) it plays in this tissue are unknown. Similarly the molecular events which either lead to the induction or derepression of expression of these sequences in human tumor cell lines and whether this also occurs in primary human tumors remains to be determined. In this regard it seems reasonable to question whether a similar NOTCH-4/INT-3 RNA species is detected in adult mouse tissues or tumors. Uyttendaele et al. (1996) surveyed normal adult mouse tissues and detected the expression of a 1.5 and 1.1 Kb NOTCH-4/INT-3 RNA species in the testis. The expression of these RNA species is restricted to the post-meiotic germ cells. Uyttendaele et al. (1996) proposed that their expression could be initiated from cryptic transcription promoters within introns of mouse NOTCH-4/INT-3. Based on the size of the two RNA species one could be initiated from sequences within intron 26 (1.5 Kb RNA species) and the other from intron 28 (1.1 Kb RNA species). Our current eorts are directed towards developing transgenic mouse strains expressing the human NOTCH-4/INT-3 1.8 Kb RNA species to determine whether over expression of this form of NOTCH-4/ INT-3 ICD has biological consequences on mammary gland development and tumorigenesis.
Materials and methods
Source and growth of tissue culture cell lines
The source of the A1N4 normal mammary epithelial cell line has been described previously (Valverius et al., 1990) . All of the other tissue culture cell lines (normal mammary epithelial cell line, MCF10A; breast tumor cell lines: BT474, Hs578T, MCF7, MDA MD 231, MDA MD 468, SKBR3, T47D, and ZR75-1; small cell lung carcinoma cell lines: NCl-H69, NCl-H82, NCl-H417, and NCl-H446; non-small cell lung carcinoma cell lines: NCl-H157, NCl-H460, and NCl-H358; colon carcinoma cell lines: SW480, HT29, COLO205, and COLO320DM) were obtained from the American Type Culture Collection (ATCC), Rockville, MD, USA. Cells were routinely cultured using the medium and growth conditions recommended by the source (Valverius et al., 1990) and ATCC. (7) were separated by 10% SDS ± PAGE followed by transfer to PVDF membrane (Immobilon-P, Millipore). The Western blot was reacted with the M2 FLAG mouse monoclonal antibody followed by horseradish peroxidase-conjugated anti-mouse immunoglobulin G antibody. A 52 kDa nonspeci®c band was observed in all of the protein extracts Novel NOTCH-4/INT-3 RNA species in human tumor cell lines A Imatani and R Callahan
Recombinant NOTCH-4/INT-3 cDNA clones
We isolated overlapping cDNA clones comprising 6.7 Kb of human NOTCH-4/INT-3 cDNA by`touchdown' polymerase chain reaction (PCR) from a human placenta adapter-ligated ds cDNA library (Marathon-Ready cDNA, Clontech). PCR products were subcloned using TA cloning Kit (Invitrogen) and sequenced using with the ALF automatic DNA sequencer (Phamacia). Sequence analysis and alignment was performed using the Sequence Analysis Software Package by Genetics Computer Group (GCG), Inc. (Smithies et al., 1981) . Within the GCG package, fragment assembly was performed by the fragment assembly system based on the method of Staden (1980) . Comparison between sequences was analysed by the BestFit sequence alignment program (Needleman et al., 1970; Smith et al., 1981) . Prior to the completion of our study Li et al. (1998) reported the complete genomic sequence (GenBank accession #U89335) of human NOTCH-4/INT-3 and the nucleotide sequence (GenBank accession #U95299) for a 6.1 Kb cDNA. Best®t analysis of the amino acid sequence of the gene products encoded by our cDNA and theirs showed that there were 13 mismatchs between the two proteins (2000 amino acid residues). Many of these mismatches are likely to be due to sequencing errors. The 5' end of our cDNA is 120 base longer then their cDNA and is identical to the genomic sequence 23865 ± 23984 bp (Li et al., 1998) . Similarily, the 3' end of our cDNA is 99% identical to the genomic nucleotide sequence between 52502 to 53093 bp.
Northern blot analysis
Total RNA was isolated from the indicated cell lines using TRIzol according to the manufacturer's instructions (Gibco, BRL). Poly(A) + RNA was puri®ed with oligo (dT) cellulose using the FastTrack 2.0 Kit (Invitrogen) according to the manufacturer's speci®cations. Human testis poly(A) + RNA was obtained from a commercial source (Clontech). Three mg of poly(A) + RNA was resolved by electrophoresis on a 0.9% agarose gel containing 6% formaldehyde. Subsequent to electrophoresis, the RNA samples were transferred to a nylon membrane Biotrans (+) Nylon Membranes, (ICN) by capillary blotting. 32 P-labeled RNA probes were transcribed in vitro by T7 RNA polymerase (Boehringer) from a human NOTCH-4/INT-3 cDNA (data not shown) encoding a 500 bp portion of the 3' untranslated sequences. This fragment is de®ned by the primers (dg934; 5'-GAATA-CATGGTAGGGAGGAATTCCAA-3'-dg785; 5'-GAGG-GAATGCAAGGAGTCATCAGC-3') and corresponds to sequences between 52504 and 52983 bp of the NOTCH-4/ INT-3 genomic sequence (Li et al., 1998) . The hybridization was performed in 56Denhardt's solution, 36SSPE (sodium chloride, sodium phosphate, EDTA)/1% SDS (sodium dodecyl sulfate), 2.5% dextran sulfate and 40% formamide at 688C for 16 h. After hybridization, the blot was washed in 2% SSC (sodium chloride, sodium citrate)/ 1% SDS once and 0.2% SSC/1% SDS twice each 30 min at 758C. The membranes were exposed to X-ray ®lm (X-OMAT AR, Kodak) for 72 h. The membranes were stripped of probed and rehybridized with b-actin cDNA to assess the relative amount of the RNA on the ®lter.
Primer extension analysis
A 37-mer oligonucleotide corresponding to NOTCH-4/INT-3 exon 27 sequences spanning 50417 ± 50453 bp of genomic DNA (5'-TCCATCCAGCAGAGGTTCCCAGGGCTCAG-GACATCCC-3') (Li et al., 1998) , was end-labeled with g-32 P-ATP and T4 polynucleotide kinase (Promega) and then used for primer extension analysis. Ten mg of total RNA from SW480 cells was denatured with 4 pmoles of the labeled oligonucleotide at 708C for 10 min, cooled to 508C and then annealed at 508C for 40 min. Extension reaction was performed at 508C for 90 min with 400 units of Superscript II reverse transcriptase (Gibco, BRL). After incubation, extension products were digested with RNAse (DNase-free), extracted with phenol/chloroform, and precipitated with ethanol. The products were analysed on a 8% denaturing polyacrylamide gel. Ten mg yeast tRNA was used as a negative control. For comparison, using the same primer, dideoxynucleotide sequencing products of intron 26 and exon 27 were electrophoretically separated in adjacent lanes of the same polyacrylamide gel.
Reverse transcriptase-polymerase chain reaction (RT ± PCR)
Five mg of total RNA from cell lines and testis were treated with DNase l, Ampli®cation Grade (Gibco, BRL) to eliminate contaminating genomic DNA. A ®rst strand cDNA was synthesized from the puri®ed total RNA at 508C for 50 min using dg933; 5'-GCAGATCCCAGTGGT-TACGTTGGTGA-3' as a gene-speci®c primer (GSP) in exon 30 (51910 ± 51935 bp of genomic DNA (Li et al., 1998) ), and Superscript II Reverse Transcriptase (Gibco, BRL). The primer dg933 was separated from cDNA using GLASSMAX SPIN Cartridge (Gibco, BRL). For each experiment, control reactions without reverse transcription were performed. After puri®cation of the cDNA, touchdown PCR was performed as described above using the primer sets; A.dg964R (exon 27) and dg841 (exon 28), Intron 26 primers: B. dg1061, C. dg1088 and D.dg1081 each with exon 28 primer dg841. The sequence of these primers corresponds to NOTCH-4/INT-3 genomic sequence (Li et al., 1998) 
(50360 ± 50384 bp); dg1061, 5'-TGTCAGAGAATTAAGCTGCAGGTTC-3' (50140 ± 50164 bp); dg1088, 5'-CCAACACCTCAGGTTTT-GATTCTCTCT-3' (50247 ± 50273 bp); dg1081, 5'-TGACC-CATTACTCTGTCTTACCAACAG-3' (50317 ± 50343 bp) and dg841; 5'-GCTGCAATCAGTTCTTCAACCAGGTC-3' (50956 ± 50981 bp). PCR products made from oligo dT primed cDNA was also performed as an internal control using the G3PDH speci®c primer set: 5'-CAGGTGGTCTCCTCTGACTTCAAC-3' and 5'-AAGGG-TCTACATGGCAACTGTGAGG-3'. PCR products were electrophoresed on 1.2% agarose gel containing TAE/EtBr (TRIS acetate, EDTA/ethidium bromide).
In vitro translation of the NOTCH-4/INT-3 gene product
The region of the NOTCH-4/INT-3 encoding the intracellular domain of the protein, beginning in the ®rst CDC 10 repeat including the initiating methionine was PCR ampli®ed from the A336 NOTCH-4/INT-3 cDNA clone (our unpublished data) using the primer set, dg XbaI+1099; 5' -GGT CTAGACA CCCCTG ATGTC AGCAG TTTGC -3' and dg XhoI+1062; 5'-GGCTCGAGCTTCTATTTTT-TACCCTCTCCTCCTTG-3'. The PCR product was cloned into the NheI and XhoI site of the pcDNA3.1(7) (Invitrogen). The protein encoded by the PCR product was synthesized using TNT Coupled Transcription/Translation System (Promega) according to the manufacturer's specifications. The synthesized protein was analysed by electrophoresis on a 10% SDS-polyacrylamide gel (SDS ± PAGE) and autoradiography.
Western blot analysis
Protein extracts from tissue culture cell lines were prepared after lysis at 48C for 10 min in a buer consisting of 0.05 M TrisHCl (pH 7.5), 0.15 MNaCl, 1% deoxycholic acid, 1% Triton X-100, 0.1% SDS, and Complete TM (protease Novel NOTCH-4/INT-3 RNA species in human tumor cell lines A Imatani and R Callahan inhibitor cocktail tablet, Boehringer Mannheim). After homogenization, lysates were centrifuged at 13 000 g for 10 min and supernatants were assayed for the protein concentration using the Bio-Rad protein assay (Bio-Rad). Fifty mg of protein for each sample was separated on a 10% Tris-Glycine polyacrylamide gel and transferred to PVDF membrane (Immobilon-P, Millipore). As a primary antibody, a polyclonal rabbit antibody (a341) against the mouse peptide sequence in 6th CDC 10 repeat: CADKDAQ DSREQTPLFLAV was used (Gallahan et al., 1996) . For Western blot analysis, the ®lters were blocked in 5% nonfat dry milk in 0.05% Tween 20 in Phosphate buered saline (PBS-T) overnight at 48C and then incubated with primary antibody (1 : 1000). After washing, the ®lters were incubated for 1 h at room temperature with 1 : 5000 diluted horseradish peroxidase-conjugated anti-rabbit immunoglobulin G antibody as a secondary antibody. For detection, enhanced chemiluminescent reaction (ECL, Amersham) was performed according to the manufacturer's speci®cation. As a negative control, the primary antibody was preincubated with the immunogenic peptide described above. To demonstrate expression of the truncated NOTCH-4/INT-3 protein by the pMcF vector Western blot analysis was performed using as a ®rst antibody, the 1 : 1000 diluted M2¯ag mouse monoclonal antibody (Kodak). The 1 : 5000 diluted horseradish peroxidase-conjugated anti-mouse immunoglobulin G antibody was used as a secondary antibody.
Expression vector
The region of NOTCH-4/INT-3 corresponding to the coding region of the 1.8 Kb RNA species (nucleotides 4855 ± 6102 bp of the Li et al. (1998) cDNA (GenBank accession # U95299, (Li et al., 1998) ) detected by Northern and RT ± PCR analysis was PCR ampli®ed from the recombinant cDNA clone A336 using dg XbaI+1099 (5'-GGTCTAGACACCCCTGATGT-CAGCAGTTTGC-3') and dg SalI+stop codon+¯ag+ 1062 (5' -GGGGTCGACCTACTTGTCATCGTCGTCCT-TGTAGTCTTTTTTACCCTCTCCTCCTTGGTTTAT -3').
The PCR product was cloned into the NheI and SalI site of pMAMneo expression vector (Clontech) and designate vector pMcF. The control vector containing no insert was designated pM.
Soft agar assay
The MCF-10A cell line, derived from normal human breast epithelium, was propagated in Dulbecco's minimal essential medium (DMEM)/F-12 (1 : 1) (Bio¯uids) supplemented with 5% horse serum, 10 ng/ml epidermal growth factor, 10 mg/ml insulin, 20 mM HEPES, 0.1 mg/ml cholera toxin 0.5 mg/ml hydrocortisone and incubated with 5% CO 2 . Five mg plasmid pMcF or pM was transfected into MCF-10A cells in a volume of 5 ml using DOTAP (Boehringer Mannheim) according to the manufacturer's speci®cations. After incubation for 12 h, the culture medium was changed with fresh media containing 600 mg/ml Geneticin (Gibco, BRL). After 2 weeks of selection, stable clones emerged. The expression of the transgene in pMcF, is inducible by dexamethasone. MCF-10A cells stably transfected with pMcF and pM were cultured in the media with or without 0.001 mM dexamethasone (Sigma) for 24 h before beginning the soft agar assay. The assay was performed using 1.5610 3 cells, in 2 ml of media containing 0.34% agarose (Seakam GTG, FMC) with or without 0.001 mM dexamethasone, were seeded into a 22 mm well with 2 ml of media containing 0.9% agarose as a base layer. Cells were incubated at 378C for approximately 6 weeks or until the colonies were visible. After staining with nitroblue tetrazolium, the number of colonies were counted using the counter (ARTEK System Corporation, NY, USA).
